ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Biomimetic Polymerization of Tellurocysteine: Breaking the Natural Amino Acid Radioprotection Limitation.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Radioprotection remains a critical challenge in biomedicine and space exploration. As the fundamental building blocks of organisms, amino acids are gaining momentum in chemical design for in vivo radioprotection, yet their low atomic number (Z) and rapid metabolism restrict practical applications. This study addresses these limitations through the melanin-inspired polymerization of the higher Z-tellurocysteine. Motivated by the superior catalytic activity and higher Z of tellurium over selenium in both enzyme mimics and microbial systems, we hypothesized that tellurium-containing amino acid polymers could demonstrate enhanced photon interaction and radical scavenging. The exceptional nucleophilic substitution capability of tellurocysteine, which arises from its soft polarizable character, drives its bisubstitution with o-benzoquinone. The heteroatom enrichment and high-Z effect make the novel materials far exceed natural amino acid polymers in radiation shielding. The melanin-mimetic polymeric structure demonstrates enhanced radiation stability and broad-spectrum free radical scavenging ability. Following oral administration, the tellurocysteine-based polymers achieve prolonged intestinal retention, mitigating radiation-induced intestinal injury. Our work establishes a new paradigm in amino acid engineering, demonstrating how strategic non-metallic heavy atom incorporation can transform biological molecules into advanced radioprotective materials. This approach opens possibilities for developing next-generation, amino acid-derived agents with tailored pharmacokinetics and multifunctional activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.